Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients.

MLA

Lim, Emerson A., et al. “Diffuse Optical Tomography Changes Correlate with Residual Cancer Burden after Neoadjuvant Chemotherapy in Breast Cancer Patients.” Breast Cancer Research and Treatment, vol. 162, no. 3, Apr. 2017, pp. 533–40. EBSCOhost, https://doi.org/10.1007/s10549-017-4150-7.

APA

Lim, E. A., Gunther, J. E., Kim, H. K., Flexman, M., Hibshoosh, H., Crew, K., Taback, B., Campbell, J., Kalinsky, K., Hielscher, A., & Hershman, D. L. (2017). Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Research and Treatment, 162(3), 533–540. https://doi.org/10.1007/s10549-017-4150-7

Chicago

Lim, Emerson A, Jacqueline E Gunther, Hyun K Kim, Molly Flexman, Hanina Hibshoosh, Katherine Crew, Bret Taback, et al. 2017. “Diffuse Optical Tomography Changes Correlate with Residual Cancer Burden after Neoadjuvant Chemotherapy in Breast Cancer Patients.” Breast Cancer Research and Treatment 162 (3): 533–40. doi:10.1007/s10549-017-4150-7.